It’s one in, one out at Reckitt Benckiser as the UK-based health and hygiene player looks to refocus its portfolio. The firm will bolster its topical pain relief offering by acquiring US brand Biofreeze, while at the same time showing the door to its Scholl foot-care brand.
RB Shows Scholl The Door, While Welcoming In Biofreeze
Reckitt is refocusing its consumer health portfolio by offloading the troubled Scholl brand and acquiring fast-growing US topical analgesic Biofreeze.
More from Deals
• By
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.
• By
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
• By
Cooper takes another step in its international expansion strategy through a partnership with Romania’s MagnaPharm for the distribution and commercialization of its self-care brand portfolio in Central and Eastern Europe (CEE).
• By
The Aurelius-owned distributor will create a new business unit especially for this purpose, headed up by business director Patrik Hene.
More from Business
• By
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
• By
Galenica outpaced the growth of the OTC market at home, while recording a double-digit gain abroad, to drive up its consumer health product sales in 2024.
• By
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.